% | $
Quotes you view appear here for quick access.

Lannett Company, Inc. Message Board

  • overstuffed_drawer overstuffed_drawer Jan 6, 2005 9:44 PM Flag

    Prospects of the Future

    from the annual report

    "Another developmental product, also an orall-administered obesity product, is a new ANDA submitted to the FDA in July 2003 for approval".

    With the average amount of time the FDA is taking to review and approve a new ANDA being 17 months, we are about due.

    So, the question now is given the lackluster stock performance as of late, is"
    1) The ANDA is no where in sight.
    2) The FDA disappoving.
    3) It's not significant.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
33.29-0.62(-1.83%)Aug 30 4:01 PMEDT